You are here » Home » Markets » Stocks » Announcements

ANNOUNCEMENTS

Announcement for "Glaxosmithkline Pharmaceuticals Ltd"

Glaxosmithkline Pharmaceuticals Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

  • 14/09/2022
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

  • 27/08/2022
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

  • 24/08/2022
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

  • 24/08/2022
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

  • 22/08/2022
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations 2015)

  • 10/08/2022
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Business Responsibility and Sustainability Reporting (BRSR)

  • 08/08/2022
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication

  • 27/07/2022
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations 2015)

  • 27/07/2022
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Shareholder Meeting / Postal Ballot-Outcome of AGM

  • 26/07/2022
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Press Release / Media Release

  • 25/07/2022
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Resignation of Director

  • 25/07/2022
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Board Meeting Outcome for Unaudited (Standalone And Consolidated) Financial Results For The First Qu

  • 25/07/2022
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Unaudited (Standalone And Consolidated) Financial Results For The First Quarter Ended 30Th June 2022

  • 25/07/2022
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

  • 06/07/2022
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Closure of Trading Window

  • 28/06/2022
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Board Meeting Intimation for Un- Audited Financial Results For The First Quarter Ended 30Th June 202

  • 28/06/2022
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Notice To Shareholders Of The Company Holding Shares In Physical Form With Regard To Norms For Furni

  • 27/06/2022
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication

  • 27/06/2022
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Reg. 34 (1) Annual Report.

  • 24/06/2022
  • |
  • bse
.